Invert
PrivateLast Round
Seed Round
Apr 1, 2026
Total Funding Raised
$20.6M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Invert operates in Healthcare & Life Sciences and is based in Copenhagen, Capital Region of Denmark. Its latest recorded funding round was a Series A round in June 2024.
Invert is a software company that provides a data analytics platform for biomanufacturing and bio-industrial companies. The platform is designed to manage, analyze, and optimize bioprocessing data, helping companies scale from the lab to full production. It eliminates data silos by connecting information from microbial genomics through to production data, enabling process analysis across different scales without requiring users to write code. The company's mission is to reduce the time and cost associated with using biology to manufacture products such as new therapies, biomaterials, and chemicals.
Sector
Healthcare & Life Sciences
Verticals
Vertical SaaS, Biotechnology, Business Intelligence, Data Integration
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Invert Comparables
Compare Invert with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Algocell | 81% | |
| DataHow AG | 79% | |
| QUBICON AG | 79% |
For institutional investors. Book with your work email.
Invert Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Apr 1, 2026 | ||||
| Series A | Jun 25, 2024 | ||||
| Seed | Jan 28, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Invert Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Positive Sum | Series A |
| Y Combinator | Series A, Seed |
| Sherpa Capital | Series A |
| Giant Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 25, 2026
Monthly visitors increased 33% MoM, reaching 5.2K.
- Apr 1, 2026
$500K Seed Round raised.
For institutional investors. Book with your work email.
Invert Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Invert's valuation, stock price, and market status.
Is Invert a public or private company?
Invert is a private company.
What is the current stock price of Invert?
Invert is a private company, so its shares have no public market price. Caplight tracks Invert's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Invert worth (valuation)?
Valuation information for Invert is not publicly available.
Can I buy Invert stock?
Invert shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Invert's last funding round?
Invert's most recent funding round was Seed Round on April 1, 2026.
Who are the main investors in Invert?
Key investors in Invert include Y Combinator.
Will Invert IPO soon?
No public IPO plans have been announced for Invert.
How can I track Invert secondary market activity?
Caplight tracks bids, offers, and trades in Invert's shares on secondary markets.